Table 2.
Angiographic characteristics of patients according to follow-up HDL-C level
| Total population | Propensity-matched population | |||||
| Low HDL-C (n=1585) | High HDL-C (n=1108) | p Value | Low HDL-C (n=990) | High HDL-C (n=990) | p Value | |
| Involved vessel | 0.002 | 0.909 | ||||
| 1VD | 654 (41.3) | 532 (48.0) | 461 (46.6) | 461 (46.6) | ||
| 2VD | 517 (32.6) | 331 (29.9) | 310 (31.3) | 303 (30.6) | ||
| 3VD | 414 (26.1) | 245 (22.1) | 219 (22.1) | 226 (22.8) | ||
| Number of B2/C lesion | 1.04±0.81 | 1.02±0.82 | 0.532 | 1.02±0.82 | 1.02±0.81 | 0.868 |
| Stent number per patient | 1.40±0.83 | 1.36±0.78 | 0.193 | 1.39±0.83 | 1.37±0.80 | 0.638 |
| Mean stent diameter, mm | 3.17±0.38 | 3.23±0.38 | <0.001 | 3.21±0.39 | 3.21±0.38 | 0.914 |
| Stent length, mm | 40.9±26.1 | 39.5±26.2 | 0.146 | 40.0±26.3 | 39.6±26.1 | 0.776 |
| Stent type | ||||||
| SES | 804 (50.7) | 547 (49.4) | 0.488 | 480 (48.5) | 499 (50.4) | 0.393 |
| PES | 472 (29.8) | 327 (29.5) | 0.882 | 293 (29.6) | 288 (29.1) | 0.805 |
| ZES | 253 (16.0) | 212 (19.1) | 0.032 | 181 (18.3) | 181 (18.3) | 1.000 |
| EES | 245 (15.5) | 172 (15.5) | 0.963 | 156 (15.8) | 157 (15.9) | 0.951 |
B2/C, complex lesion; EES, everolimus-eluting stent; HDL-C, high-density lipoprotein cholesterol; PES, paclitaxel-eluting stent; SES, sirolimus-eluting stent; VD, vessel disease; ZES, zotarolimus-eluting stent.